Cargando…
High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients
Circulating tumour DNA (ctDNA) is an emerging field of cancer research. However, current ctDNA analysis is usually restricted to one or a few mutation sites due to technical limitations. In the case of massively parallel DNA sequencers, the number of false positives caused by a high read error rate...
Autores principales: | Kukita, Yoji, Matoba, Ryo, Uchida, Junji, Hamakawa, Takuya, Doki, Yuichiro, Imamura, Fumio, Kato, Kikuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535617/ https://www.ncbi.nlm.nih.gov/pubmed/26126624 http://dx.doi.org/10.1093/dnares/dsv010 |
Ejemplares similares
-
Transient appearance of circulating tumor DNA associated with de novo treatment
por: Kato, Kikuya, et al.
Publicado: (2016) -
Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment
por: Kunimasa, Kei, et al.
Publicado: (2019) -
Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data
por: Kukita, Yoji, et al.
Publicado: (2013) -
HLA genotyping by next-generation sequencing of complementary DNA
por: Segawa, Hidenobu, et al.
Publicado: (2017) -
Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
por: Imamura, Fumio, et al.
Publicado: (2016)